Anne Rombaut

Artiklar

Article: MOLECULAR BRAIN. 2025;18(1):54
Systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma
Mouhammad ZA; Rombaut A; Bermudez MYG; Vohra R; Tribble JR; Williams PA; Kolko M
Article: CELL REPORTS MEDICINE. 2025;6(5):102127
Dysfunctional one-carbon metabolism identifies vitamins B6, B9, B12, and choline as neuroprotective in glaucoma
Tribble JR; Wong VHY; Stuart KV; Chidlow G; Nicol A; Rombaut A; Rabiolo A; Hoang A; Lee PY; Rutigliani C; Enz TJ; Canovai A; Lardner E; Stalhammar G; Nguyen CTO; Garway-Heath DF; Casson RJ; Khawaja AP; Bui BV; Williams PA
Article: MOLECULAR BRAIN. 2024;17(1):84
Intravitreal injection of the Galectin-3 inhibitor TD139 provides neuroprotection in a rat model of ocular hypertensive glaucoma
Rombaut A; Brautaset R; Williams PA; Tribble JR
Article: ACTA NEUROPATHOLOGICA COMMUNICATIONS. 2024;12(1):79
Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection
Rombaut A; Jovancevic D; Wong RC-B; Nicol A; Brautaset R; Finkelstein DI; Nguyen CTO; Tribble JR; Williams PA

Review: FRONTIERS IN OPHTHALMOLOGY. 2023;3:1290465
Glial metabolic alterations during glaucoma pathogenesis
Rombaut A; Brautaset R; Williams PA; Tribble JR